Publications by authors named "Takeshi Shinozaki"

Objective: The impact of suture materials on surgical site infections (SSIs) has been well documented in various surgical fields; however, it has not been thoroughly examined in oral oncological surgery with free-flap reconstruction. This study aimed to evaluate the incidence of oral SSIs associated with the use of monofilament and braided sutures for flap fixation.

Methods: A retrospective chart review of patients who underwent oral oncological resection with free-flap reconstruction was conducted between May 2020 and April 2024.

View Article and Find Full Text PDF

Background: We investigate the feasibility of using artificial intelligence (AI) to identify the recurrent laryngeal nerve (RLN) during endoscopic thyroid surgery and evaluated its accuracy.

Methods: In this retrospective study, we develop an AI model using a dataset of endoscopic thyroid surgery videos, including hemithyroidectomy procedures performed between April 2019 and September 2023 at the National Cancer Center Hospital East, Chiba, Japan. Semantic segmentation deep learning methods were applied to analyze the endoscopic thyroid surgery videos.

View Article and Find Full Text PDF

: Near-infrared photoimmunotherapy (NIR-PIT) was recently approved for the treatment of unresectable locally advanced or recurrent head and neck cancers in Japan; however, only one clinical dose has been validated in clinical trials, potentially resulting in excessive or insufficient dosing. Moreover, IRDye700X (IR700) fluorescence intensity plateaus during treatment, indicating a particular threshold for the antitumor effects. Therefore, we investigated the NIR laser dose across varying tumor sizes and irradiation methods until the antitumor effects of the fluorescence decay rate plateaued.

View Article and Find Full Text PDF

Background: The significance of induction chemotherapy (IC) in the treatment of squamous cell carcinoma of the head and neck (SCCHN) with unresectable locoregional recurrence after curative surgery has not been clarified. The aim of this study was to evaluate the efficacy of IC followed by chemoradiotherapy (CRT) in these patients.

Methods: Among patients with unresectable locoregional recurrent SCCHN who had not undergone prior irradiation and were eligible for cisplatin, we conducted a retrospective analysis of patients who received CRT following IC with paclitaxel, carboplatin, or cetuximab (IC-PCE group) and those who received CRT without prior IC (CRT group) between June 2013 and August 2021.

View Article and Find Full Text PDF

Sublingual gland herniation into the submandibular space through a mylohyoid muscle defect is a common anatomical variation; however, salivary gland cancers that arise from a herniated sublingual gland have not been described yet. Here, we report three patients with salivary gland cancers originating from a herniated sublingual gland. All tumors were detected as palpable submandibular masses, located anterior to the submandibular gland, medial to the mandible, and lateral to the mylohyoid muscle, with contact with the sublingual gland through a mylohyoid muscle defect.

View Article and Find Full Text PDF
Article Synopsis
  • Enhanced recovery after surgery programs are designed to decrease surgery-related invasiveness and improve recovery, with early enteral nutrition and mobilization being key elements, though their safety in head and neck surgery remains uncertain.
  • A retrospective study comparing conventional and early management methods found that early management significantly reduced major complications and wound infections in patients undergoing head and neck surgery with free tissue transfer.
  • While the early management group showed slightly lower compliance rates compared to the conventional group, the study concluded that early management is a safe and effective approach to enhance postoperative recovery in this surgical context.
View Article and Find Full Text PDF

Posttreatment imaging surveillance of head and neck cancer is challenging owing to complex anatomic subsites and diverse treatment modalities. Early detection of residual disease or recurrence through surveillance imaging is crucial for devising optimal treatment strategies. Posttreatment imaging surveillance is performed using CT, fluorine 18-fluorodeoxyglucose PET/CT, and MRI.

View Article and Find Full Text PDF

Photoimmunotherapy is a new treatment modality in which a tumor-targeting monoclonal antibody is combined with a photoactivated dye and a laser is applied to destroy tumor cells. In Japan, insurance reimbursement for this treatment started in January 2021 for unresectable locally advanced or locally recurrent head and neck cancer. We used photoimmunotherapy to treat two patients with recurrent nasopharyngeal squamous cell carcinoma (NPSCC).

View Article and Find Full Text PDF
Article Synopsis
  • The study examined the effects of postoperative radiotherapy (PORT) after salvage neck dissection for patients with cervical lymph node recurrence in oral cavity cancer, focusing on outcomes like survival and recurrence rates.
  • After following 51 patients for about 7.4 years, the results showed a 7-year overall survival rate of 66.3% and a recurrence-free survival rate of 54.6%, with better outcomes for younger patients and those with isolated lymph node recurrence.
  • While PORT was effective, some patients experienced side effects like severe acute mucositis (35%) and less common long-term issues like osteoradionecrosis (4%) and laryngeal stenosis (2%).
View Article and Find Full Text PDF

Photoimmunotherapy is a novel cancer treatment that recently became covered by national health insurance in Japan, but treatment decision-making remains challenging for unresectable advanced or recurrent head and neck cancer. We aimed to clarify the characteristics of patients for whom photoimmunotherapy was indicated by a retrospective chart review. Patients aged ≥20 years diagnosed with advanced or recurrent head and neck cancer who started receiving systemic therapy at the National Cancer Center Hospital East from January 2016 through December 2020 were retrospectively analyzed.

View Article and Find Full Text PDF
Article Synopsis
  • - The "Japanese Clinical Practice Guidelines for Head and Neck Cancer - 2022 Update" aims to review and update standard diagnosis and treatment approaches based on the latest evidence in the field.
  • - Developed by a diverse committee of experts, including surgeons, oncologists, and rehabilitation specialists, these guidelines are based on the previous 2018 edition and include input from public feedback.
  • - The guidelines address 59 clinical questions across 13 categories, with a focus on six specific clinical questions and their corresponding recommendations and comments.
View Article and Find Full Text PDF

Background: Endoscopic-assisted transoral surgery (TOS) for superficial cancer of the pharyngo-esophageal junction (PEJ) is risk of stricture, and therapeutic outcomes are unclear. This study aimed to evaluate clinical outcomes of endoscopic-assisted TOS for superficial PEJ cancers.

Methods: We retrospectively compared clinical outcomes of endoscopic-assisted TOS for superficial PEJ cancers (group A) and of other sites in the hypopharynx (group B).

View Article and Find Full Text PDF
Article Synopsis
  • The study analyzes the effectiveness of local therapies (LT) like surgery and radiotherapy in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) who have previously undergone treatment with the immune checkpoint inhibitor nivolumab.
  • A retrospective review involved 24 patients, with 37.5% receiving salvage LT and 62.5% undergoing palliative radiotherapy. The outcomes varied significantly based on the type of treatment received, with median overall survival (OS) ranging from 24.5 months to 2.4 months.
  • The findings suggest that for R/M SCCHN patients treated with nivolumab, salvage LT followed by systemic therapy is associated with better survival outcomes,
View Article and Find Full Text PDF

Introduction: There is no established methodology for the perioperative management of head and neck cancer surgery and free tissue transfer reconstruction (HNS-FTR). A single dose of corticosteroid administered immediately before surgery has been shown to reduce postoperative pain and nausea/vomiting after some types of surgery. However, the efficacy of this strategy has not been demonstrated in HNS-FTR, and the increased risk of infectious complications associated with its use cannot be ruled out.

View Article and Find Full Text PDF

Chronic expanding hematoma (CEH) is defined as chronic hematoma enlargement for more than 1 month. Although CEH rarely occurs on the floor of the mouth, the need to distinguish these cases from malignant disease is critical, given the need for potentially extensive resection in patients with malignancy. We report a case of CEH on the floor of the mouth, which required differentiation from malignant tumor.

View Article and Find Full Text PDF
Article Synopsis
  • Polyglycolic acid (PGA) sheets are used with fibrin glue in oral and pharyngeal surgeries to cover mucosal defects, but issues with sheet falling off have led to recommendations for prolonged fasting during recovery.
  • A study analyzing 137 patients found that Neoveil Nano® PGA sheets significantly improved engraftment rates compared to Neoveil®, with a 76% overall engraftment rate.
  • The research concluded that fasting duration does not impact engraftment success, suggesting that patients can safely resume oral intake earlier than previously advised.
View Article and Find Full Text PDF

This sentinel node (SN) biopsy trial aimed to assess its effectiveness in identifying predictive factors of micrometastases and to determine whether elective neck dissection is necessary in oral squamous cell carcinoma. This retrospective study included 55 patients from three previous trials, with positive SNs. The relationship between the sizes of the metastatic focus and metastasis in non-sentinel node (NSN) was investigated.

View Article and Find Full Text PDF

Background: The entire pharynx should be observed endoscopically to avoid missing pharyngeal lesions. An artificial intelligence (AI) model recognizing anatomical locations can help identify blind spots. We developed and evaluated an AI model classifying pharyngeal and laryngeal endoscopic locations.

View Article and Find Full Text PDF

One of the most severe side effects of photoimmunotherapy (PIT) for head and neck cancer is pain. As there are presently no detailed reports on pain and pain management in PIT, we conducted a retrospective case series study. We conducted a retrospective study of five patients who had received PIT at the National Cancer Center Hospital East between January 2021 and June 2022 using medical chart data.

View Article and Find Full Text PDF

Background: A multicenter, randomized controlled phase III trial was conducted on sentinel lymph node biopsy (SLNB) and elective neck dissection for T1 (depth of invasion ≥ 4 mm)-T2N0M0 oral cavity squamous cell carcinoma. This study identified factors associated with poor prognosis in patients who underwent SLNB based on a subgroup analysis of this trial.

Methods: We analyzed 418 sentinel lymph nodes (SLNs) from 132 patients who underwent SLNB.

View Article and Find Full Text PDF

Fibroepithelial polyp (FEP) is a common benign tumor occurring in the skin and genitourinary tract, and there are no reports of multiple FEPs occurring on the myocutaneous flap. We report two cases of FEPs occurring diffusely on the skin tissue of the free anterolateral thigh flap after surgical reconstruction for oral squamous cell carcinoma. Clinically, multiple papillary nodules on the myocutaneous flap gradually increased.

View Article and Find Full Text PDF

Objectives: Investigation of the prognosis of young patients with tongue carcinoma has been the focus of several recent studies aimed at improving future precision treatment. Most studies have been two-cohort investigations comparing young and older patients, who have wide discrepancies in prognosis. Older patients, especially those aged >70 years, often have a poor general condition.

View Article and Find Full Text PDF
Article Synopsis
  • - HNC-PIT is a new localized treatment for head and neck cancer that combines a cancer-targeting drug (cetuximab) with a dye (IRdye700DX) activated by near-infrared light, and it received conditional approval in Japan in 2020 for specific advanced cancer cases.
  • - The effectiveness of HNC-PIT for treating local recurrence of nasopharyngeal squamous cell carcinoma (NPSCC) is still being studied, particularly since outcomes aren’t yet clear.
  • - A case study involving a 77-year-old male with recurring NPSCC showed promising results after HNC-PIT treatment, as the patient remained recurrence-free and without adverse effects seven months post-procedure
View Article and Find Full Text PDF

Objectives: Understanding the miss rate and characteristics of missed pharyngeal and laryngeal cancers during upper gastrointestinal endoscopy may aid in reducing the endoscopic miss rate of this cancer type. However, little is known regarding the miss rate and characteristics of such cancers. Therefore, the aim of this study was to investigate the upper gastrointestinal endoscopic miss rate of oro-hypopharyngeal and laryngeal cancers, the characteristics of the missed cancers, and risk factors associated with the missed cancers.

View Article and Find Full Text PDF